158 related articles for article (PubMed ID: 17122512)
21. Intraductal papillary-mucinous neoplasms of the gastric and intestinal types may have less malignant potential than the pancreatobiliary type.
Takasu N; Kimura W; Moriya T; Hirai I; Takeshita A; Kamio Y; Nomura T
Pancreas; 2010 Jul; 39(5):604-10. PubMed ID: 20124938
[TBL] [Abstract][Full Text] [Related]
22. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas.
Tanaka M; Fernández-del Castillo C; Adsay V; Chari S; Falconi M; Jang JY; Kimura W; Levy P; Pitman MB; Schmidt CM; Shimizu M; Wolfgang CL; Yamaguchi K; Yamao K;
Pancreatology; 2012; 12(3):183-97. PubMed ID: 22687371
[TBL] [Abstract][Full Text] [Related]
23. GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma.
Tan MC; Basturk O; Brannon AR; Bhanot U; Scott SN; Bouvier N; LaFemina J; Jarnagin WR; Berger MF; Klimstra D; Allen PJ
J Am Coll Surg; 2015 May; 220(5):845-854.e1. PubMed ID: 25840541
[TBL] [Abstract][Full Text] [Related]
24. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas.
Tanaka M; Fernández-Del Castillo C; Kamisawa T; Jang JY; Levy P; Ohtsuka T; Salvia R; Shimizu Y; Tada M; Wolfgang CL
Pancreatology; 2017; 17(5):738-753. PubMed ID: 28735806
[TBL] [Abstract][Full Text] [Related]
25. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients.
Pelaez-Luna M; Chari ST; Smyrk TC; Takahashi N; Clain JE; Levy MJ; Pearson RK; Petersen BT; Topazian MD; Vege SS; Kendrick M; Farnell MB
Am J Gastroenterol; 2007 Aug; 102(8):1759-64. PubMed ID: 17686073
[TBL] [Abstract][Full Text] [Related]
26. Interobserver variability in intraductal papillary mucinous neoplasm subtypes and application of their mucin immunoprofiles.
Kwak HA; Liu X; Allende DS; Pai RK; Hart J; Xiao SY
Mod Pathol; 2016 Sep; 29(9):977-84. PubMed ID: 27198568
[TBL] [Abstract][Full Text] [Related]
27. Acute pancreatitis in intraductal papillary mucinous neoplasm: a single-center retrospective cohort study with systematic review and meta-analysis.
Xu JH; Ni CY; Zhuang YY; Li L; Lin Y; Xia ZS; Wu WR; Chen QK; Zhong W
BMC Gastroenterol; 2023 Dec; 23(1):424. PubMed ID: 38041073
[TBL] [Abstract][Full Text] [Related]
28. Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.
Adsay V; Mino-Kenudson M; Furukawa T; Basturk O; Zamboni G; Marchegiani G; Bassi C; Salvia R; Malleo G; Paiella S; Wolfgang CL; Matthaei H; Offerhaus GJ; Adham M; Bruno MJ; Reid MD; Krasinskas A; Klöppel G; Ohike N; Tajiri T; Jang KT; Roa JC; Allen P; Fernández-del Castillo C; Jang JY; Klimstra DS; Hruban RH;
Ann Surg; 2016 Jan; 263(1):162-77. PubMed ID: 25775066
[TBL] [Abstract][Full Text] [Related]
29. Carcinogenesis of pancreatic adenocarcinoma: precursor lesions.
Gnoni A; Licchetta A; Scarpa A; Azzariti A; Brunetti AE; Simone G; Nardulli P; Santini D; Aieta M; Delcuratolo S; Silvestris N
Int J Mol Sci; 2013 Sep; 14(10):19731-62. PubMed ID: 24084722
[TBL] [Abstract][Full Text] [Related]
30. Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes.
Mino-Kenudson M; Fernández-del Castillo C; Baba Y; Valsangkar NP; Liss AS; Hsu M; Correa-Gallego C; Ingkakul T; Perez Johnston R; Turner BG; Androutsopoulos V; Deshpande V; McGrath D; Sahani DV; Brugge WR; Ogino S; Pitman MB; Warshaw AL; Thayer SP
Gut; 2011 Dec; 60(12):1712-20. PubMed ID: 21508421
[TBL] [Abstract][Full Text] [Related]
31. Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas.
Maker AV; Katabi N; Qin LX; Klimstra DS; Schattner M; Brennan MF; Jarnagin WR; Allen PJ
Clin Cancer Res; 2011 Mar; 17(6):1502-8. PubMed ID: 21266527
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas.
Maker AV; Katabi N; Gonen M; DeMatteo RP; D'Angelica MI; Fong Y; Jarnagin WR; Brennan MF; Allen PJ
Ann Surg Oncol; 2011 Jan; 18(1):199-206. PubMed ID: 20717734
[TBL] [Abstract][Full Text] [Related]
33. Comparison of histologic subtype and growth pattern in intraductal papillary-mucinous carcinoma of the pancreas.
Sanada Y; Kunita S; Yoshida K
Oncol Rep; 2008 Jun; 19(6):1435-43. PubMed ID: 18497948
[TBL] [Abstract][Full Text] [Related]
34. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
[TBL] [Abstract][Full Text] [Related]
35. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
[TBL] [Abstract][Full Text] [Related]
36. Current understanding of precursors to pancreatic cancer.
Takaori K
J Hepatobiliary Pancreat Surg; 2007; 14(3):217-23. PubMed ID: 17520195
[TBL] [Abstract][Full Text] [Related]
37. Intraductal papillary mucinous neoplasms of the pancreas: clinical and pathological features and diagnostic approach.
Katabi N; Klimstra DS
J Clin Pathol; 2008 Dec; 61(12):1303-13. PubMed ID: 18703569
[TBL] [Abstract][Full Text] [Related]
38. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.
Ban S; Naitoh Y; Mino-Kenudson M; Sakurai T; Kuroda M; Koyama I; Lauwers GY; Shimizu M
Am J Surg Pathol; 2006 Dec; 30(12):1561-9. PubMed ID: 17122512
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
